Advanced gastric cancer achieving major pathologic regression after chemoimmunotherapy combined with hypofractionated radiotherapy: A case report

por Zhou, Meng-Long, Xu, Ruo-Ne, Tan, Cong, Zhang, Zhen, Wan, Jue-Feng
Publicado 2023

Postoperative chemoradiotherapy versus chemotherapy for R0 resected gastric cancer with D2 lymph node dissection: an up-to-date meta-analysis

por Zhou, Meng-long, Kang, Mei, Li, Gui-chao, Guo, Xiao-mao, Zhang, Zhen
Publicado 2016

Validation of the Memorial Sloan Kettering Cancer Center nomogram to predict disease-specific survival in a Chinese gastric cancer population receiving postoperative chemoradiother...

por Zhou, Meng-long, Wang, Lei, Wang, Jia-zhou, Yang, Wang, Hu, Ran, Li, Gui-chao, Sheng, Wei-qi, Zhang, Zhen
Publicado 2016

Immune Score Predicts Outcomes of Gastric Cancer Patients Treated with Adjuvant Chemoradiotherapy

por Zou, Wei, Zhou, Meng-long, Zhang, Ling-yi, Yang, Jia-ning, Yang, Wang, Wang, Ya-qi, Yi, Yu-xi, Li, Gui-chao, Zhang, Zhen
Publicado 2021

Adjuvant chemoradiotherapy versus adjuvant chemotherapy for patients with N3 gastric cancer after D2/R0 resection: a retrospective study based on propensity score analyses

por Zhou, Meng-Long, Yang, Wang, Wang, Ya-Qi, Mo, Miao, Hu, Ran, Wang, Yan, Yang, Jia-Ning, Li, Gui-Chao, Wang, Ya-Nong, Zhang, Zhen
Publicado 2019